SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat

Article citations


Morre, T.D., Hamels, K., Clement, P.A. and Bourgain, C. (1998) Nasal Mucosal Sarcoidosis: A Case Report. Acta Oto-Rhino-Laryngologica Belgica, 52, 75-77.

has been cited by the following article:

  • TITLE: Systemic Sarcoidosis Revealed by a Nasal Lesion: A Case Report

    AUTHORS: Madiha Mahfoudhi, Khaled Khammassi, Sami Turki, Mamia Ben Salah

    KEYWORDS: Sarcoidosis, Nose, Granuloma, Corticosteroids

    JOURNAL NAME: International Journal of Clinical Medicine, Vol.6 No.4, April 16, 2015

    ABSTRACT: A 62-year-old man presented with bilateral nasal obstruction and recurrent epistaxis episodes. Physical examination revealed normal body temperature and free cervical lymph nodes areas. Nasal endoscopy found a congestive nasal mucosa associated to bilateral inferior turbinate hypertrophy with a granular aspect of the right inferior turbinate. The biological examination showed lymphopenia, inflammatory syndrome, high serum level of angiotensin-converting enzyme and β2 microglobulin. Tuberculin skin test and Quantiferon gold were negative. The nasal and accessory salivary gland biopsies revealed granulomatous giant cell lesions non-caseating evoking systemic sarcoidosis. Ziehl-Neelsen staining and Lowenstein culture were negative. The diagnosis was systemic sarcoidosis revealed by nasal localization. The systemic extension research was negative. The treatment was based on corticosteroids (1 mg/kg/day) and gradual degression doses associated to a local nasal corticosteroid. The outcome was favorable with improvement of nasal obstruction and disappearance of initial lesions. The follow-up was 2 years.